LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The rationale of the study is to determine:
- the first dose and the titration of basal insulin
- the exact daily time administration of basal insulin in poorly controlled type II
diabetic patients.